Cargando…

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer

BACKGROUND: Gastric cancer (GC) is one of the most common cancer worldwide. It is essential to identify non-invasive diagnostic and prognostic biomarkers of GC. The aim of the present study was to screen candidate biomarkers associated with the pathogenesis and prognosis of GC by a novel strategy. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lei, Pang, Honglin, He, Qiao, Pan, Biran, Sun, Xiaobin, Shan, Jing, Wu, Liping, Wu, Kaiwen, Yao, Xue, Guo, Yuanbiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254335/ https://www.ncbi.nlm.nih.gov/pubmed/34215253 http://dx.doi.org/10.1186/s12935-021-02007-6

Ejemplares similares

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
por: Sun, Jiaxing, et al.
Publicado: (2020)

Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing
por: Zhao, Xu, et al.
Publicado: (2021)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer
por: Zhang, Meng, et al.
Publicado: (2020)

AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma
por: Feng, Ziyang, et al.
Publicado: (2022)

A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020)

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
por: Wu, Fan, et al.
Publicado: (2018)

As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway
por: Ma, Shuo, et al.
Publicado: (2021)

SNAP25 is a potential prognostic biomarker for prostate cancer
por: Di, Longjiang, et al.
Publicado: (2022)

Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients
por: Yuan, Jingping, et al.
Publicado: (2019)

Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma
por: Xia, Tian, et al.
Publicado: (2021)

Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients
por: Zhou, Liqiang, et al.
Publicado: (2021)

Twenty-six circulating antigens and two novel diagnostic candidate molecules identified in the serum of canines with experimental acute toxoplasmosis
por: Xue, Junxin, et al.
Publicado: (2016)

Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
por: Li, Tian-Fu, et al.
Publicado: (2020)

Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis
por: Wu, Zhengxin, et al.
Publicado: (2021)

Identifying positive selection candidate loci for high-altitude adaptation in Andean populations
por: Bigham, Abigail W, et al.
Publicado: (2009)

Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
por: Went, Molly, et al.
Publicado: (2019)

Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining
por: Abouelhoda, Mohamed, et al.
Publicado: (2021)

Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera
por: Hirvonen, Elina A. M., et al.
Publicado: (2017)

The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma
por: Wei, Jing, et al.
Publicado: (2019)

Volatile organic metabolites identify patients with gastric carcinoma, gastric ulcer, or gastritis and control patients
por: Tong, Hongshuang, et al.
Publicado: (2017)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020)

MiR-7 inhibits progression of hepatocarcinoma by targeting KLF-4 and promises a novel diagnostic biomarker
por: Wu, Weizhong, et al.
Publicado: (2017)

Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma
por: Xiong, Fei, et al.
Publicado: (2021)

Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer
por: Peng, Jianhong, et al.
Publicado: (2021)

Whole exome sequencing identifies novel candidate genes that modify chronic obstructive pulmonary disease susceptibility
por: Bruse, Shannon, et al.
Publicado: (2016)

MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates
por: Jiménez Martín, Ovidio, et al.
Publicado: (2021)

PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
por: Sun, Yifan, et al.
Publicado: (2019)

Hypomethylation and downregulation of miR-23b-3p are associated with upregulated PLAU: a diagnostic and prognostic biomarker in head and neck squamous cell carcinoma
por: Huo, Zirong, et al.
Publicado: (2021)

Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients
por: Qiu, Jieping, et al.
Publicado: (2020)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
por: Wang, Peng, et al.
Publicado: (2020)

SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer
por: Dai, Wumin, et al.
Publicado: (2021)

Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma
por: Pang, Yilin, et al.
Publicado: (2021)

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
por: Tao, Wenjie, et al.
Publicado: (2021)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model
por: Zhang, Enchong, et al.
Publicado: (2021)

Analyzing the lncRNA, miRNA, and mRNA-associated ceRNA networks to reveal potential prognostic biomarkers for glioblastoma multiforme
por: Zhu, Xiaolong, et al.
Publicado: (2020)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j026jb9cg9s20r0ornvp0btru1